Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

HAKAN KAYA

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1255320974
CMS profile
56985
Location
SPOKANE, WA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$310,612.18

189 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
Karyopharm Therapeutics Inc. $163,358.37 95
Takeda Pharmaceuticals U.S.A., Inc. $49,080.09 26
GlaxoSmithKline, LLC. $39,375.94 21
GENZYME CORPORATION $29,195.96 20
Janssen Biotech, Inc. $11,851.03 7
Amgen Inc. $9,377.58 6
Epizyme, Inc., $4,068.87 5
Incyte Corporation $3,520.00 3
Celgene Corporation $609.09 2
E.R. Squibb & Sons, L.L.C. $100.02 1
AbbVie Inc. $49.38 1
Acrotech Biopharma LLC $13.93 1
Gilead Sciences, Inc. $11.92 1

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

189 matching records · $310,612.18 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 189 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 189.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Karyopharm Therapeutics Inc. $8,125.0012/09/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845785211 CMS
Karyopharm Therapeutics Inc. $7.8412/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845785233 CMS
Karyopharm Therapeutics Inc. $1,389.2612/09/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845785361 CMS
Karyopharm Therapeutics Inc. $346.8112/09/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845785369 CMS
GlaxoSmithKline, LLC. $67.4012/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026801753873 CMS
Karyopharm Therapeutics Inc. $8,125.0012/02/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845785251 CMS
Karyopharm Therapeutics Inc. $168.3212/02/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845785253 CMS
Karyopharm Therapeutics Inc. $68.0012/02/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845785327 CMS
Karyopharm Therapeutics Inc. $473.4812/02/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845785349 CMS
GlaxoSmithKline, LLC. $4,200.0011/22/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026803130627 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,570.0011/19/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026820011527 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,570.0011/19/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026820011531 CMS
Janssen Biotech, Inc. $3,575.0011/18/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026788036529 CMS
Epizyme, Inc., $576.8011/17/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026832340801 CMS
Karyopharm Therapeutics Inc. $8,125.0011/16/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845785191 CMS
Karyopharm Therapeutics Inc. $403.4911/16/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845785199 CMS
Karyopharm Therapeutics Inc. $5.3211/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845785237 CMS
Karyopharm Therapeutics Inc. $15.3211/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845785263 CMS
Karyopharm Therapeutics Inc. $17.8611/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845785279 CMS
Karyopharm Therapeutics Inc. $22.0011/16/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845785295 CMS
Karyopharm Therapeutics Inc. $23.4911/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845785309 CMS
Karyopharm Therapeutics Inc. $226.6311/16/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845785345 CMS
Karyopharm Therapeutics Inc. $9.0711/16/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845785363 CMS
Karyopharm Therapeutics Inc. $831.2511/16/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845785367 CMS
GENZYME CORPORATION $1,852.0011/11/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843496951 CMS
GENZYME CORPORATION $536.0211/11/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843496953 CMS
Takeda Pharmaceuticals U.S.A., Inc. $7,850.0011/11/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026820011523 CMS
Karyopharm Therapeutics Inc. $13.8911/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845785225 CMS
Karyopharm Therapeutics Inc. $4,063.0011/09/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845785273 CMS
Takeda Pharmaceuticals U.S.A., Inc. $34.4011/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026820011519 CMS
Janssen Biotech, Inc. $550.0011/08/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026788036525 CMS
Takeda Pharmaceuticals U.S.A., Inc. $115.9611/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026820011511 CMS
Takeda Pharmaceuticals U.S.A., Inc. $603.6011/04/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026820011515 CMS
Janssen Biotech, Inc. $71.1211/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026788036527 CMS
Karyopharm Therapeutics Inc. $8,700.0010/29/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845785373 CMS
Amgen Inc. $3,000.0010/28/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026826344511 CMS
Takeda Pharmaceuticals U.S.A., Inc. $7,850.0010/28/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026820011507 CMS
GlaxoSmithKline, LLC. $97.7210/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026802025825 CMS
Karyopharm Therapeutics Inc. $596.8110/26/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845785219 CMS
Takeda Pharmaceuticals U.S.A., Inc. $744.6510/22/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026820011495 CMS
Takeda Pharmaceuticals U.S.A., Inc. $163.4010/22/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026820011499 CMS
Takeda Pharmaceuticals U.S.A., Inc. $123.9810/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026820011503 CMS
GlaxoSmithKline, LLC. $1,400.0010/19/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026803190893 CMS
Takeda Pharmaceuticals U.S.A., Inc. $338.8610/11/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026820011491 CMS
Takeda Pharmaceuticals U.S.A., Inc. $7,850.0010/07/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026820011487 CMS
GlaxoSmithKline, LLC. $4,200.0010/05/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026803104385 CMS
Karyopharm Therapeutics Inc. $1,940.0010/04/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026845785231 CMS
Takeda Pharmaceuticals U.S.A., Inc. $30.8310/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026820011483 CMS
Takeda Pharmaceuticals U.S.A., Inc. $525.4510/01/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026820011479 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.9609/30/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026820011467 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $229,005.23 161
PY2020 $242,762.69 163
PY2021 $310,612.18 189
PY2022 $359,271.69 219
PY2023 $319,762.05 232
PY2024 $420,082.03 326
PY2025 $302,193.27 329

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
HAKAN KAYA, NPI 1255320974. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1255320974.
APA 7
IndustryPayments. (2026). HAKAN KAYA, NPI 1255320974 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1255320974
Bluebook
HAKAN KAYA, NPI 1255320974, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1255320974.

Source: Centers for Medicare & Medicaid Services, Open Payments.